Treatment

JNJ-87562761 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma
This study is testing a new medicine, JNJ-87562761, for multiple myeloma that has come back or not responded to past treatments. Its main goals are to find a safe and effective dose and understand any side effects.
For: Relapsed or Refractory Multiple Myeloma
Canada · South Korea · Spain